Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein SA pseudogene 48 (RPSAP48) is a pseudogene within the RPSA multicopy family. Pseudogenes are generally non-functional DNA sequences derived from functional genes by duplications or retrotranspositions. Unlike the parent ribosomal protein SA gene (RPSA), which encodes a multifunctional protein implicated in ribosome assembly and cell surface interactions (especially as a laminin receptor), RPSAP48 is not known to encode any protein or possess any well-characterized biological or therapeutic function. Most RPSA pseudogenes are thought to have arisen from retrotranspositional events, and there is no evidence that RPSAP48 acts as a druggable receptor, enzyme, or transporter[3][7][5]. Some RPSA pseudogenes may be transcribed and could possibly act as regulatory RNAs, but definitive data for RPSAP48 specifically are lacking[7]. The main functional RPSA gene is linked to cancer and other diseases, but these roles do not extend to the pseudogene RPSAP48 unless future research reveals non-coding regulatory activities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein SA pseudogene 48 (RPSAP48).